Metoprolol Ratiopharm (Metoprolol Tartrate)

Metoprolol blocks β1‑adrenergic receptors in the heart, reducing the effects of norepinephrine and epinephrine. This leads to a slower heart rate, decreased contractile force, and lower cardiac output, which together lower blood pressure and myocardial oxygen demand.

The appropriate dose is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and any concomitant medications. Dosage may be adjusted over time to achieve the desired therapeutic effect while minimizing side effects.

Safety data for metoprolol in pregnancy are limited, and the drug should only be used if the potential benefit justifies any potential risk to the fetus. Metoprolol is excreted in breast milk; breastfeeding mothers should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is cardio‑selective, primarily affecting β1 receptors, which generally results in fewer respiratory side effects compared with non‑selective agents like propranolol. Compared with atenolol, metoprolol has a shorter half‑life and may require twice‑daily dosing, but both share similar efficacy for blood‑pressure control.

Store the tablets at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Metoprolol Ratiopharm is taken orally, usually with a glass of water. It can be taken with or without food, but the same conditions (with or without meals) should be maintained each day to ensure consistent absorption.

Serious adverse events include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with underlying airway disease, and rare allergic reactions. Patients should seek immediate medical attention if they experience fainting, severe shortness of breath, or a rapid worsening of symptoms.

Metoprolol is contraindicated in individuals with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, decompensated heart failure, overt cardiogenic shock, and uncontrolled asthma or severe chronic obstructive pulmonary disease.